Masimo Corp (MASI)
171.23
+2.66
(+1.58%)
USD |
NASDAQ |
Jan 03, 16:00
171.24
+0.01
(+0.01%)
After-Hours: 20:00
Masimo Research and Development Expense (Annual): 175.20M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Abbott Laboratories | 2.741B |
AngioDynamics Inc | 31.51M |
Boston Scientific Corp | 1.414B |
Globus Medical Inc | 124.01M |
Tandem Diabetes Care Inc | 248.42M |